Effect of antenatal corticosteroid on early neonatal outcome in preterm neonates: a prospective observational study

Joy Christ H., Praveen B. K.


Background: Respiratory distress syndrome (RDS) is the most common complication observed in preterm neonates. It has been observed in many studies done till date that neonates born to mothers who have received antenatal corticosteroids (ACS) have shown significantly lesser incidence in developing RDS as compared to neonates born to mothers who have not received ACS. The aim of the present study is to observe and compare the outcome of the neonates born to the mothers who have received and not received ACS between 24 weeks + 0 days to 36 weeks + 6 days of gestation.

Methods: This was a hospital based prospective observational study, consisting of 201 neonates born to the mothers who have received and not received ACS between 24 weeks + 0 days and 36 weeks + 6 days of gestation. The outcome of neonates was observed and the data was analyzed by using frequency percentage and pearson’s chi square test.

Results: Two hundred and one neonates were included in our study. It was concluded that the need of surfactant (P=0.004), CPAP (P=0.001) was significantly less and the rate of survival (P=0.000) was better in babies born to mothers who have received ACS in comparison to neonates born to mothers who have not received ACS.

Conclusions: It was observed that in neonates there was significantly lesser incidence of respiratory distress syndrome, use of surfactant, CPAP, ventilation and number of deaths. But there was no significant statistical difference in incidence of necrotizing enterocolitis, sepsis, and PDA as compared to neonates born to mothers who have not received ACS. Hence it will require further study and analysis in a larger population. 


Antenatal corticosteroids, Respiratory distress syndrome, Pearson’s chi square test, Sepsis

Full Text:



Meneguel JF, Guinsburg R, Miyoshi MH, Araujo Peres C. Antenatal treatment with corticosteroids for preterm neonates:impact on the incidence of respiratory distress syndrome and intra-hospitalmortality. Sao Paulo Med J. 2003;121(2):45-52.

Schimmer BP, Parket KL. Hormônio adreno corticotrófico;esteróides adrenocorticais e seus análogos sintéticos; inibidoresda síntese e das ações dos hormônios adrenocorticais. In: Gilman AG, Rall TW, Nies AS, eds. Godman & Gilman’s - As basesfarmacológicas da terapêutica. Rio de Janeiro: McGraw-Hill;1996;1082:102.

Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol. 1995;173(1):254-62.

National Institutes of Health Effect of corticosteroids for fetal maturation on perinatal outcome. NIH Consensus Statement.Washington: NIH. 1994;12:1-24.

Merrill JD, Ballard RA. Clinical use of antenatal corticosteroids: benefits and risks. Pediatr Rev. 2000;1(5):91-8.

Wang YC, Tseng HI, Yang SN, et al Effects of antenatal corticosteroids on neonatal outcomes in very-low-birth-weight preterm newborns: a 10-year retrospective study in a medical center. Pediatr Neonatol. 2012;53(3):178-83.

Sen S, Reghu A, Ferguson S. Efficacy of a single dose of antenatal steroid in surfactant-treated babies under 31 weeks’gestation. J Matern Fetal Neonatal Med. 2002;12:298-303.

Wapner RJ, Sorokin Y, Mele L. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357(12):1190-8.

Abbasi S, Hirsch D, Davis J, Tolosa J, Stouffer N, Debbs R, et al. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am J Obstet Gynecol. 2000;182(5):1243-9.

Sasidharan P. Role of corticosteroids in neonatal

blood pressurehomeostasis. Clin Perinatol. 1998;25(3):723-40.